Showing 1751-1760 of 2150 results for "".
- ImprimisRx to Assume Full Responsibility for US Sales and Marketing Activities for Dexycuhttps://modernod.com/news/imprimisrx-to-assume-full-responsibility-for-us-sales-and-marketing-activities-for-dexycu/2480499/EyePoint Pharmaceut
- iSTAR Medical Receives European Market Approval for Glaucoma Implant MINIjecthttps://modernod.com/news/istar-medical-receives-european-market-approval-for-glaucoma-implant-miniject/2480460/iSTAR Medical
- In-Office MGD Procedure Market is Largely Untapped, Survey Showshttps://modernod.com/news/in-office-mgd-procedure-market-is-largely-untapped-survey-shows/2480424/Doctors in the US and Europe diagnose approximately two-thirds of their dry eye patients with evaporative dry eye but treat very few of them in the office for meibom
- Horizon Therapeutics to Resupply Market With Tepezza for the Treatment of Thyroid Eye Disease (TED) Beginning in Aprilhttps://modernod.com/news/horizon-therapeutics-to-resupply-market-with-tepezza-for-the-treatment-of-thyroid-eye-disease-ted-beginning-in-april/2479043/Horizon Therapeutics announced that the FDA has approved a prior approval supplement (PAS) to the previously approved Biologics Licensing Application (BLA) giving Horizon authorization to manufacture more Tepezza drug product resulting in an increased number of vials with each manufacturing slot.
- FTC to Probe Physician Practice Consolidation and Impact on Market Competitionhttps://modernod.com/news/ftc-to-probe-physician-practice-consolidation-and-impact-on-market-competition/2478787/The federal government plans to study the impact of physician group and healthcare facility consolidation during the past six years, according to a FierceHealthcare
- Innovations Will Propel OCT Market to $549 Million in Revenue in 2020https://modernod.com/news/innovations-will-propel-oct-market-to-549-million-in-revenue-in-202/2478426/Recent innovations in optical coherence tomography (OCT) technology—such as systems that are combined with fundus imagers—and software advancements, including OCT angiography, are growing in popularity. At the same time promising new technologies on the horizon, such as at-home OCT devices, are g
- COVID-19 Has Flipped the Physician Job Search to a Seller’s Market, Recruiters Sayhttps://modernod.com/news/covid-19-has-flipped-the-physician-job-search-to-a-sellers-market-recruiters-say/2478020/Job opportunities for doctors have dried up quite a bit in wake of the COVID-19 pandemic, at least in the short term, according to an annual report from physician search firm Merritt Hawkins, according to a FierceHealthcare
- New Alcon Program Aims to Help ECPs Tap Into Opportunities in the Dry Eye Market Amid COVID-19 Crisishttps://modernod.com/news/new-alcon-program-aims-to-help-ecps-tap-into-opportunities-in-the-dry-eye-market-amid-covid-19-crisis/2477838/Alcon has launched a new program called “No Reason to Wait: Success Starts Now” aimed at helping eye care professionals (ECPs) better understand the practice and patient benefits of treating the root cause of evaporat
- FDA, CDC, NIH to Begin Validating COVID-19 Antibody Tests as More Enter the Markethttps://modernod.com/news/fda-cdc-nih-to-begin-validating-covid-19-antibody-tests-as-more-enter-the-market/2477624/As the US begins to turn to antibody testing to help navigate new phases of the COVID-19 pandemic, an interagency collaboration will aim to evaluate these diagnostic products and their accuracy, according to a FierceBiotech
- Market Scope: New Cataract Atlas Identifies Location of Premium IOLs and High Volume Surgeonshttps://modernod.com/news/market-scope-new-cataract-atlas-identifies-location-of-premium-iols-and-high-volume-surgeons/2477348/The metro areas of New York, Los Angeles, Dallas, and Chicago account for 14 percent of the population over 60 in the US. However, on a per capita share basis, most of the metro areas in Florida stand out for their potential pool of cataract patients, driven largely by the state’s high median age